Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 217
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

    If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

    T Cell Vaccines as an Immunotherapy for Type 1 Diabetes

    Type 1 Diabetes develops when CD4+ T cells aren't taught to differentiate between self-antigens and foreign...

    Backer Badge Funded